Last week, researchers from across the world gathered in Washington, D.C., for the annual Alzheimer's Association International Conference. The team from the ADDF was there to discuss recent findings in drug discovery and prevention research and meet with our grantees and partners.
The conference featured a section on Technology and Dementia, with discussions on how emerging technologies could revolutionize research and patient care. Our takeaways follow:
Aaron Carman, PhD, was previously the Assistant Director of Aging and Alzheimer's Prevention at the Alzheimer's Drug Discovery Foundation. Dr. Carman received his doctorate in microbiology and molecular genetics from The University of Texas Health Science Center at Houston.
Get the latest brain health news: